Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Jun;41(6):1355-1359.
doi: 10.1007/s10072-020-04450-1. Epub 2020 May 19.

An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)

Affiliations
Clinical Trial

An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)

Carlo Ferrarese et al. Neurol Sci. 2020 Jun.

Abstract

Neurological manifestations of COVID-19 have been described in both single case reports and retrospective scanty case series. They may be linked to the potential neurotropism of the SARS-COV-2 virus, as previously demonstrated for other coronaviruses. We report here the description of a multicenter retrospective-prospective observational study promoted by the Italian Society of Neurology (SIN), involving the Italian Neurological Departments, who will consecutively recruit patients with neurological symptoms and/or signs, occurred at the onset or as a complication of COVID-19. Hospitalized patients will be recruited either in neurological wards or in COVID wards; in the latter cases, they will be referred from other specialists to participant neurologists. Outpatients with clinical signs of COVID and neurological manifestations will be also referred to participating neurologists from primary care physicians. A comprehensive data collection, in the form of electronic case report form (eCRF), will register all possible neurological manifestations involving central nervous systems, peripheral nerves, and muscles, together with clinical, laboratory (including cerebrospinal fluid, if available), imaging, neurological, neurophysiological, and neuropsychological data. A follow-up at hospital discharge (in hospitalized patients), and for all patients after 3 and 6 months, is also planned. We believe that this study may help to intercept the full spectrum of neurological manifestations of COVID-19 and, given the large diffusion at national level, can provide a large cohort of patients available for future more focused investigations. Similar observational studies might also be proposed at international level to better define the neurological involvement of COVID-19.

Keywords: COVID-19; NEUROCOVID; Neurological manifestations; Observational study.

PubMed Disclaimer

Conflict of interest statement

CF is in the Editorial Board of Parkinson Disease and Neurological Sciences; Coordinator of PRIN 2017, Grant: 2017CY3J3W, received grants and compensations for consulting services from Biogen, DOCPharma, Merck, Roche.

VS is in the Editorial Board of Amyotroph Lateral Sclerosis, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology; received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, and Zambon; and receives or has received research supports from the Italian Minsitry of Health (Grant RF-201302355764), Fondazione Italiana di Ricerca per la SLA – AriSLA (Grants exomafals and Novals), Fondazione Regionale per la Ricerca Biomedica regione Lombarda (Project nr. 2015-0023), and E-RARE JTC 2018 (Project Repetomics).

APr, APa, EA, GT, SG, and SM have nothing to disclose.

References

    1. Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, Viiganò M, Giovannelli G, Pirro F, Montisano DA, Appollonio I, Ferrarese C (2020) Guillain-Barré syndrome related to COVID-19 infection, Neurology. Neuroimmunol Neuroinflamm 7(4)e741 - PMC - PubMed
    1. Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12(3):e7352. - PMC - PubMed
    1. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, Rusconi S, Gervasoni C, Ridolfo AL, Rizzardini G, Antinori S, Galli M (2020) Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis pii: ciaa330. doi: 10.1093/cid/ciaa330 - PMC - PubMed
    1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol doi: 10.1001/jamaneurol.2020.1127 - PMC - PubMed
    1. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun pii: S0889-1591(20)30357-3. doi: 10.1016/j.bbi.2020.03.031 - PMC - PubMed